Levi’s, Gap, and American Eagle are spending huge sums on advertising to sell their jeans amid a new denim boom.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
A potential tie-up would come at an interesting crossroads for the theatrical industry and its longtime nemesis, Netflix.
Dollar General said Thursday that third-quarter revenue rose 4.6% to $10.6 billion and net profit 44% to $283 million.
Trump said the Biden administration proposal “forced automakers to build cars using expensive technologies that drove up costs” and prices.
For now at least, it looks like the storied retail company’s turnaround effort is taking hold as well as paying off.
The rosy projections sent Boeing shares up more than 10% on Tuesday, rubbing salt in the wounds of its archrival Airbus.
Shoppers in the US will be able to buy the new foldable during the first quarter of 2026, though the pricing hasn’t been shared yet.
State officials greenlit three new casino projects in New York City on Monday, setting the stage for a new era of gambling in the Big Apple.
Anduril was last valued at $30 billion in June, when its $2.5 billion fundraising round was oversubscribed eight times.
Gone are the days where you had to wander endless thrift stores and sift through racks to find the perfect pair of previously owned jeans.
US shoppers are now paying an average price of $6.60 per pound of ground beef, according to the US Bureau of Labor Statistics.
The success of indie titles may help video game makers rely less on blockbusters and widen creative license, creating a 1UP for players.
Kohl’s is the largest US department store chain by number of retail locations, with more than double the number operated by Macy’s.
Artificial intelligence can do a lot of things. Getting us on an exercise bike doesn’t appear to be one of them.
Peace deal or no peace deal, the war in Ukraine is motivating governments on the continent to upgrade their defensive capacity.
The trial proved so successful that Bayer plans to reach out to regulators in preparation for submitting the drug candidate for approval.